ERBB2 and Hyperinsulinemia: Our group previously reported how hyperinsulinemia can induce hyperactivation of esophageal receptors for insulin and IGF-1, and how their impairment and the commitment of other growth factor receptors, such as HER2, can mediate insulin’s pro-proliferative effect on precancerous and cancerous esophageal cells [5].